GenScript

GenScript Biotech Corporation, founded in 2002 in New Jersey, is a prominent global biotechnology company focused on life science research and development, as well as manufacturing services. Publicly listed on the Hong Kong Stock Exchange since 2015, GenScript operates in over 100 countries and employs more than 6,900 people. The company is recognized as the largest provider of gene synthesis services and has a significant impact on scientific research, with citations in over 103,600 peer-reviewed articles and a robust intellectual property portfolio of over 300 patents. GenScript's operations are organized into four main business platforms: Life Science Services and Products, Biologics Contract Development and Manufacturing, Global Cell Therapy, and Industrial Synthetic Biological Products. The company offers a wide range of services, including custom gene synthesis, CRISPR gene editing, antibody production, and biologics manufacturing. GenScript also develops advanced cell therapies, such as CAR-T treatments, in collaboration with major pharmaceutical companies. With a diverse customer base of over 200,000 clients, GenScript is committed to advancing biotechnology through continuous investment in research and development.